<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract" xml:lang="en"><front><journal-meta><journal-id journal-id-type="nlm-ta">J Foot Ankle Res</journal-id><journal-id journal-id-type="iso-abbrev">J Foot Ankle Res</journal-id><journal-title-group><journal-title>Journal of Foot and Ankle Research</journal-title></journal-title-group><issn pub-type="epub">1757-1146</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">3668955</article-id><article-id pub-id-type="publisher-id">1757-1146-6-S1-O8</article-id><article-id pub-id-type="doi">10.1186/1757-1146-6-S1-O8</article-id><article-categories><subj-group subj-group-type="heading"><subject>Oral Presentation</subject></subj-group></article-categories><title-group><article-title>Effectiveness of trigger point dry needling for plantar heel pain: a randomized controlled trial</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>Cotchett</surname><given-names>Matthew P</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><xref ref-type="aff" rid="I3">3</xref><email>m.cotchett@latrobe.edu.au</email></contrib><contrib contrib-type="author" id="A2"><name><surname>Landorf</surname><given-names>Karl B</given-names></name><xref ref-type="aff" rid="I2">2</xref><xref ref-type="aff" rid="I3">3</xref></contrib><contrib contrib-type="author" id="A3"><name><surname>Munteanu</surname><given-names>Shannon E</given-names></name><xref ref-type="aff" rid="I2">2</xref><xref ref-type="aff" rid="I3">3</xref></contrib></contrib-group><aff id="I1"><label>1</label>Department of Allied Health, La Trobe Rural Health School, La Trobe University, Melbourne, Australia</aff><aff id="I2"><label>2</label>Department of Podiatry, La Trobe University, Melbourne, Australia</aff><aff id="I3"><label>3</label>Lower Extremity and Gait Studies Program, La Trobe University, Melbourne, Australia</aff><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub"><day>31</day><month>5</month><year>2013</year></pub-date><volume>6</volume><issue>Suppl 1</issue><supplement><named-content content-type="supplement-title">Proceedings of the Australasian Podiatry Council Conference 2013</named-content><named-content content-type="supplement-editor">Stefania Penkala</named-content><named-content content-type="supplement-sponsor">Publication of this supplement was funded by the Australasian Podiatry Council Conference.</named-content></supplement><fpage>O8</fpage><lpage>O8</lpage><permissions><copyright-statement>Copyright © 2013 Cotchett et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2013</copyright-year><copyright-holder>Cotchett et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="http://www.jfootankleres.com/content/6/S1/O8"></self-uri><conference><conf-date>2-5 June 2013</conf-date><conf-name>Australasian Podiatry Council Conference 2013</conf-name><conf-loc>Sydney, Australia</conf-loc></conference></article-meta></front><body><sec><title><offsets xml_i="3717" xml_f="3727" txt_i="7" txt_f="17">Background</offsets></title><p><offsets xml_i="3738" xml_f="4030" txt_i="18" txt_f="310">Plantar heel pain (plantar fasciitis) can be managed with myofascial trigger point dry needling of myofascial trigger points, however there is only poor quality evidence supporting its use. Therefore, we aimed to evaluate the effectiveness of trigger point dry needling for plantar heel pain.</offsets></p></sec><sec sec-type="methods"><title><offsets xml_i="4071" xml_f="4078" txt_i="312" txt_f="319">Methods</offsets></title><p><offsets xml_i="4089" xml_f="4581" txt_i="320" txt_f="812">84 participants with plantar heel pain were randomized to real or sham trigger point dry needling. The intervention consisted of one treatment per week for six weeks. Participants were followed for 12 weeks. Primary outcome measures included ‘first-step pain’ measured with a Visual Analogue Scale and foot pain measured with the pain subscale of the Foot Health Status Questionnaire. The primary end-point for predicting the effectiveness of dry needling for plantar heel pain was six weeks.</offsets></p></sec><sec sec-type="results"><title><offsets xml_i="4622" xml_f="4629" txt_i="814" txt_f="821">Results</offsets></title><p><offsets xml_i="4640" xml_f="4823" txt_i="822" txt_f="1005">At the primary end-point, significant effects favored real dry needling over sham dry needling for pain (adjusted mean difference: VAS first-step pain -14.4 mm, 95% CI -23.5 to -5.2, </offsets><italic><offsets xml_i="4831" xml_f="4832" txt_i="1005" txt_f="1006">p</offsets></italic><offsets xml_i="4841" xml_f="4897" txt_i="1006" txt_f="1062">=0.002; FHSQ foot pain 10.0 points, 95% CI 1.0 to 19.1, </offsets><italic><offsets xml_i="4905" xml_f="4906" txt_i="1062" txt_f="1063">p</offsets></italic><offsets xml_i="4915" xml_f="5219" txt_i="1063" txt_f="1364">=0.029), although the between-group difference was lower than the minimal important difference. The frequency of minor transitory adverse events was significantly greater in the real dry needling group (70 real dry needling appointments [32%] compared with only 1 sham dry needling appointment [&lt;1%]).</offsets></p></sec><sec sec-type="conclusions"><title><offsets xml_i="5264" xml_f="5274" txt_i="1366" txt_f="1376">Conclusion</offsets></title><p><offsets xml_i="5285" xml_f="5493" txt_i="1377" txt_f="1585">We found that dry needling provided statistically significant improvements in plantar heel pain, but the magnitude of this effect should be considered against the frequency of minor transitory adverse events.</offsets></p></sec></body></article>